Displaying items by tag: division of hematology and oncology

Treating blood disorders and cancers cannot be done alone. It requires the strong will of a patient, the support of family, and the compassion and expertise of a world-renowned health care team, like those with the O’Neal Comprehensive Cancer Center at UAB’s Bone Marrow Transplantation and Cell Therapy program.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
Cancer centers nationwide, including the O’Neal Comprehensive Cancer Center at UAB as a leading site, are joining together to address the impact of COVID-19 pandemic on cancer prevention and treatment.
Delays in cancer screenings due to the coronavirus could lead to thousands of cancer deaths in the coming years. O’Neal Comprehensive Cancer Center at UAB is vigilant in its efforts to provide uninterrupted care to patients.
The O’Neal Comprehensive Cancer Center has been designated a Center of Excellence by the Myelodysplastic Syndromes Foundation, making it the only one in the state that holds this designation and can now provide patients access to an international network of specialized physicians.
In the first study of its kind, researchers identified genetic factors that can lead to a decrease in cognitive ability after a blood or bone marrow transplant.
Joining the Erdheim-Chester Disease Care Center Network has made UAB one of the 33 centers that can treat ECD.

A harrowing diagnosis shook Luis Hurtado to his core, but the Blazer hoops player and Collat School of Business student beat the disease with the help of his UAB family.

UAB will launch the Pat and Jean Sullivan Comprehensive Head and Neck Cancer Survivor Care Program in 2020 — the first effort of its kind in the country.

A UAB researcher’s involvement in clinical trials helped approve a first-of-its-kind targeted medication to reduce pain crisis for individuals with sickle cell disease.

Page 2 of 6